CD3 and IL-23 receptor binding bispecific constructs and their use in the treatment of various diseases
US10077312B2 · kind B2 · utility
3Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 2014 |
| Grant date | Sep 18, 2018 |
| Priority date | — |
| Expiry date | May 12, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to bispecific constructs that specifically bind to immune effector cells and, simultaneously, to IL23R-carrying target cells, as well as nucleic acids, vectors, host cells, pharmaceutical compositions, and methods of production and use thereof, including such bispecific constructs for use in treating inflammatory and/or autoimmune diseases and/or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.